Log in to save to my catalogue

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, act...

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, act...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_914667616

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

Publication information

Publisher

London: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Twice-daily raltegravir with once-daily tenofovir-emtricitabine is an effective initial antiretroviral regimen for patients with HIV-1. On the basis of pharmacokinetic data suggesting efficacy of once-daily raltegravir and because adherence is often improved with once-daily dosing, we aimed to compare these dosing schedules. Meth...

Alternative Titles

Full title

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_914667616

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_914667616

Other Identifiers

ISSN

1473-3099

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(11)70196-7

How to access this item